FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2936645220> ?p ?o ?g. }

• W2936645220 endingPage "501" @default.
• W2936645220 startingPage "492" @default.
• W2936645220 abstract "Nitrogen-containing heterocycles such as quinoline, quinazolinones and indole are scaffolds of natural products and have broad biological effects. During the last years those structures have been intensively synthesized and modified to yield new synthetic molecules that can specifically inhibit the activity of dysregulated protein kinases in cancer cells. Herein, a series of newly synthesized isoquinolinamine (FX-1 to 8) and isoindoloquinazolinone (FX-9, FX-42, FX-43) compounds were evaluated in regards to their anti-leukemic potential on human B- and T- acute lymphoblastic leukemia (ALL) cells. Several biological effects were observed. B-ALL cells (SEM, RS4;11) were more sensitive against isoquinolinamine compounds than T-ALL cells (Jurkat, CEM). In SEM cells, metabolic activity decreased with 10 μM up to 26.7% (FX-3), 25.2% (FX-7) and 14.5% (FX-8). The 3-(p-Tolyl) isoquinolin-1-amine FX-9 was the most effective agent against B- and T-ALL cells with IC50 values ranging from 0.54 to 1.94 μM. None of the tested compounds displayed hemolysis on erythrocytes or cytotoxicity against healthy leukocytes. Anti-proliferative effect of FX-9 was associated with changes in cell morphology and apoptosis induction. Further, influence of FX-9 on PI3K/AKT, MAPK and JAK/STAT signaling was detected but was heterogeneous. Functional inhibition testing of 58 kinases revealed no specific inhibitory activity among cancer related kinases. In conclusion, FX-9 displays significant antileukemic activity in B- and T-ALL cells and should be further evaluated in regards to the mechanisms of action. Further compounds of the current series might serve as templates for the design of new compounds and as basic structures for modification approaches." @default.
• W2936645220 created "2019-04-25" @default.
• W2936645220 creator A5000983166 @default.
• W2936645220 creator A5005182277 @default.
• W2936645220 creator A5006621343 @default.
• W2936645220 creator A5007271388 @default.
• W2936645220 creator A5015709398 @default.
• W2936645220 creator A5055468693 @default.
• W2936645220 creator A5058003965 @default.
• W2936645220 creator A5079524945 @default.
• W2936645220 creator A5091378068 @default.
• W2936645220 date "2019-09-01" @default.
• W2936645220 modified "2023-09-27" @default.
• W2936645220 title "Novel Isoquinolinamine and Isoindoloquinazolinone Compounds Exhibit Antiproliferative Activity in Acute Lymphoblastic Leukemia Cells" @default.
• W2936645220 cites W1503514494 @default.
• W2936645220 cites W1608710587 @default.
• W2936645220 cites W161836838 @default.
• W2936645220 cites W1882359529 @default.
• W2936645220 cites W1966942042 @default.
• W2936645220 cites W1968225251 @default.
• W2936645220 cites W1977455716 @default.
• W2936645220 cites W2023528999 @default.
• W2936645220 cites W2028744406 @default.
• W2936645220 cites W2033822461 @default.
• W2936645220 cites W2041896919 @default.
• W2936645220 cites W2042638141 @default.
• W2936645220 cites W2042657119 @default.
• W2936645220 cites W2053391598 @default.
• W2936645220 cites W2066404978 @default.
• W2936645220 cites W2075101707 @default.
• W2936645220 cites W2077385921 @default.
• W2936645220 cites W2080167560 @default.
• W2936645220 cites W2099066961 @default.
• W2936645220 cites W2108384965 @default.
• W2936645220 cites W2132033628 @default.
• W2936645220 cites W2132691559 @default.
• W2936645220 cites W2141158380 @default.
• W2936645220 cites W2162382186 @default.
• W2936645220 cites W2203365682 @default.
• W2936645220 cites W2297753032 @default.
• W2936645220 cites W2302518824 @default.
• W2936645220 cites W2305253637 @default.
• W2936645220 cites W2414096785 @default.
• W2936645220 cites W2414895566 @default.
• W2936645220 cites W2531561799 @default.
• W2936645220 cites W2546817359 @default.
• W2936645220 cites W2590525769 @default.
• W2936645220 cites W2604936949 @default.
• W2936645220 cites W2605478093 @default.
• W2936645220 cites W2612238179 @default.
• W2936645220 cites W2635415917 @default.
• W2936645220 cites W2725970815 @default.
• W2936645220 cites W2747045489 @default.
• W2936645220 cites W2760129444 @default.
• W2936645220 cites W2761881371 @default.
• W2936645220 cites W2765144049 @default.
• W2936645220 cites W2790161043 @default.
• W2936645220 cites W2794119433 @default.
• W2936645220 cites W2885210489 @default.
• W2936645220 cites W2885781055 @default.
• W2936645220 cites W2895099432 @default.
• W2936645220 doi "https://doi.org/10.4062/biomolther.2018.199" @default.
• W2936645220 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6720533" @default.
• W2936645220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30971063" @default.
• W2936645220 hasPublicationYear "2019" @default.
• W2936645220 type Work @default.
• W2936645220 sameAs 2936645220 @default.
• W2936645220 citedByCount "9" @default.
• W2936645220 countsByYear W29366452202019 @default.
• W2936645220 countsByYear W29366452202020 @default.
• W2936645220 countsByYear W29366452202021 @default.
• W2936645220 countsByYear W29366452202022 @default.
• W2936645220 countsByYear W29366452202023 @default.
• W2936645220 crossrefType "journal-article" @default.
• W2936645220 hasAuthorship W2936645220A5000983166 @default.
• W2936645220 hasAuthorship W2936645220A5005182277 @default.
• W2936645220 hasAuthorship W2936645220A5006621343 @default.
• W2936645220 hasAuthorship W2936645220A5007271388 @default.
• W2936645220 hasAuthorship W2936645220A5015709398 @default.
• W2936645220 hasAuthorship W2936645220A5055468693 @default.
• W2936645220 hasAuthorship W2936645220A5058003965 @default.
• W2936645220 hasAuthorship W2936645220A5079524945 @default.
• W2936645220 hasAuthorship W2936645220A5091378068 @default.
• W2936645220 hasBestOaLocation W29366452202 @default.
• W2936645220 hasConcept C109316439 @default.
• W2936645220 hasConcept C121608353 @default.
• W2936645220 hasConcept C126322002 @default.
• W2936645220 hasConcept C179464577 @default.
• W2936645220 hasConcept C184235292 @default.
• W2936645220 hasConcept C185592680 @default.
• W2936645220 hasConcept C202751555 @default.
• W2936645220 hasConcept C203014093 @default.
• W2936645220 hasConcept C2776090121 @default.
• W2936645220 hasConcept C2778461978 @default.
• W2936645220 hasConcept C502942594 @default.
• W2936645220 hasConcept C55493867 @default.
• W2936645220 hasConcept C71924100 @default.
• W2936645220 hasConcept C86803240 @default.

• next